Incidence of Alzheimer’s disease in a rural community in India
The Indo–US Study
Abstract
Objective: To determine overall and age-specific incidence rates of AD in a rural, population-based cohort in Ballabgarh, India, and to compare them with those of a reference US population in the Monongahela Valley of Pennsylvania.
Methods: A 2-year, prospective, epidemiologic study of subjects aged ≥55 years utilizing repeated cognitive and functional ability screening, followed by standardized clinical evaluation using the Diagnostic and Statistical Manual of Mental Disorders, 4th edition, and the National Institute of Neurological and Communicative Disorders and Stroke–Alzheimer’s Disease and Related Disorders Association criteria for the diagnosis, and the Clinical Dementia Rating scale for the staging, of dementia and AD.
Results: Incidence rates per 1000 person–years for AD with CDR ≥0.5 were 3.24 (95% CI: 1.48–6.14) for those aged ≥65 years and 1.74 (95% CI: 0.84–3.20) for those aged ≥55 years. Standardized against the age distribution of the 1990 US Census, the overall incidence rate in those aged ≥65 years was 4.7 per 1000 person–years, substantially lower than the corresponding rate of 17.5 per 1000 person–years in the Monongahela Valley.
Conclusion: These are the first AD incidence rates to be reported from the Indian subcontinent, and they appear to be among the lowest ever reported. However, the relatively short duration of follow-up, cultural factors, and other potential confounders suggest caution in interpreting this finding.
Get full access to this article
View all available purchase options and get full access to this article.
References
1.
World Health Organization (WHO). Population ageing—a public health challenge. Fact Sheet No. 135. Geneva: World Health Organization, 1998.
2.
Jorm AF, Jolley D. The incidence of dementia. A meta-analysis. Neurology . 1998; 51: 728–733.
3.
Li G, Shen YC, Chen CH, Zhau YW, Li SR, Lu M. An epidemiological survey of age-related dementia in an urban area of Beijing. Acta Psychiatr Scand . 1989; 79: 557–563.
4.
Zhang M, Katzman R, Salmon D, et al. The prevalence of dementia and Alzheimer’s disease in Shanghai China; impact of age, gender and education. Ann Neurol . 1990; 27: 428–437.
5.
Hendrie HC, Osuntokun BO, Hall KS, et al. Prevalence of Alzheimer’s disease and dementia in two communities: Nigerian Africans and African Americans. Am J Psychiatr . 1995; 152: 1485–1492.
6.
Rajkumar S, Kumar S, Thara R. Prevalence of dementia in a rural setting: a report from India. Int J Geriatr Psychiat . 1997; 12: 702–707.
7.
Shaji S, Promodu K, Abraham T, Roy KJ, Verghese A. An epidemiological study of dementia in a rural community of Kerala, India. Br J Psychiatr . 1996; 168: 745–749.
8.
Chandra V, Ganguli M, Pandav R, Johnston J, Belle S, DeKosky ST. Prevalence of Alzheimer’s disease and other dementias in rural India: the Indo–US Study. Neurology . 1998; 51: 1000–1008.
9.
Zhang M, Katzman R, Yu E, Liu W, Xiao SF, Yan H. A preliminary analysis of incidence of dementia in Shanghai, China. Psychiatry Clin Neurosci . 1998; 52 (suppl): S291–S294.
10.
Yoshitake T, Kiyohara Y, Kato I, et al. Incidence and risk factors of vascular dementia and Alzheimer’s disease in a defined elderly Japanese population: the Hisayama study. Neurology . 1995; 45: 1161–1168.
11.
Liu CK, Lai CL, Tai CT, Lin RT, Yen YY, Howng SL. Incidence and subtypes of dementia in southern Taiwan: impact of socio-demographic factors. Neurology . 1998; 50: 1572–1579.
12.
Hendrie HC, Ogunniyi A, Hall KS, et al. Incidence of dementia and Alzheimer disease in 2 communities: Yoruba residing in Ibadan, Nigeria, and African Americans residing in Indianapolis, Indiana. JAMA . 2001; 285: 739–747.
13.
Ganguli M, Ratcliff G, Chandra V, et al. A Hindi version of the MMSE: the development of a cognitive screening instrument for a largely illiterate rural elderly population in India. Int J Geriatr Psychiat . 1995; 10: 367–377.
14.
Ganguli M, Chandra V, Gilby JE, et al. Cognitive test performance in a community-based non-demented elderly sample in rural India: the Indo–US Cross-National Dementia Epidemiology Study. Int Psychogeriatr . 1996; 8: 507–524.
15.
Fillenbaum GG, Chandra V, Ganguli M, et al. Development of an Activities of Daily Living scale to screen for dementia in an illiterate rural older population in India. Age Ageing . 1999; 28: 161–168.
16.
Chandra V, DeKosky ST, Pandav R, et al. Neurologic factors associated with cognitive impairment in a rural elderly population in India: the Indo–US Cross-National Dementia Epidemiology Study. J Geriatr Psychiatry Neurol . 1998; 11: 11–17.
17.
Ganguli M, Dodge HH, Chen P, Belle S, DeKosky ST. Ten year incidence of dementia in a rural elderly U.S. community population: The MoVIES Project. Neurology . 2000; 54: 1109–1116.
18.
Morris JC, Heyman A, Mohs RC, et al. The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer’s disease. Neurology . 1989; 39: 1159–1165.
19.
Folstein MF, Folstein SE, McHugh PR. Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res . 1975; 12: 189–198.
20.
Kukull WA, Ganguli M. Epidemiology of dementia: concepts and overview. In: DeKosky ST, ed. Dementia. Neurol Clin 2000; 18: 923–949.
21.
American Psychiatric Association. DSM-IV. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association, 1994.
22.
Hughes CP, Berg L, Danziger WL, Cohen LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatr . 1982; 140: 566–572.
23.
McKhann G, Drachman D, Folstein MF, Katzman T, Price D, Stadlan EM. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Service Task Force on Alzheimer’s disease. Neurology . 1984; 34: 939–944.
24.
1990 Census of Population. General population characteristics. Washington, DC: Bureau of the Census Government Printing Office, 1992.
25.
Cohen A. Excess female mortality in India: the case of Himachal Pradesh. Am J Public Health . 2000; 90: 1369–1371.
26.
Ganguli M, Chandra V, Kamboh MI, et al. APOE polymorphism and Alzheimer’s disease: the Indo–US Cross-National Dementia Study. Arch Neurol . 2000; 57: 824–830.
27.
Ganguli M, Belle S, Ratcliff G, et al. Sensitivity and specificity for dementia of population-based criteria for cognitive impairment: the MoVIES project. J Gerontol (Med Sci) . 1993; 48: M152–M161.
Information & Authors
Information
Published In
Copyright
© 2001.
Publication History
Received: September 28, 2000
Accepted: May 17, 2001
Published online: September 25, 2001
Published in issue: September 25, 2001
Authors
Metrics & Citations
Metrics
Citation information is sourced from Crossref Cited-by service.
Citations
Download Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
Cited By
- Neuroblastoma, Plant-Based Therapeutics, Volume 3, (577-618), (2025).https://doi.org/10.1007/978-3-032-04239-2_12
- Cross-cultural functional assessment for dementia: A commentary, The Clinical Neuropsychologist, (1-26), (2025).https://doi.org/10.1080/13854046.2025.2543913
- Addressing global diversity in dementia research with the COSMIC collaboration, Neuroscience, 582, (180-194), (2025).https://doi.org/10.1016/j.neuroscience.2025.07.036
- Transthyretin Amyloidosis: Role of oxidative stress and the beneficial implications of antioxidants and nutraceutical supplementation, Neurochemistry International, 179, (105837), (2024).https://doi.org/10.1016/j.neuint.2024.105837
- Oral Health-Related Quality of Life (OHRQoL) in Elderly Patients with and without Alzheimer’s Disease - An Evaluative Study, Indian Journal of Dental Research, 35, 2, (149-153), (2024).https://doi.org/10.4103/ijdr.ijdr_792_21
- Role of Epigenetic Modulation in Neurodegenerative Diseases: Implications of Phytochemical Interventions, Antioxidants, 13, 5, (606), (2024).https://doi.org/10.3390/antiox13050606
- Alzheimer’s diseases in America, Europe, and Asian regions: a global genetic variation, PeerJ, 12, (e17339), (2024).https://doi.org/10.7717/peerj.17339
- Types of memory, dementia, Alzheimer’s disease, and their various pathological cascades as targets for potential pharmacological drugs, Ageing Research Reviews, 96, (102289), (2024).https://doi.org/10.1016/j.arr.2024.102289
- Antioxidant, anti‐inflammatory and epigenetic potential of curcumin in Alzheimer's disease, BioFactors, 50, 4, (693-708), (2024).https://doi.org/10.1002/biof.2039
- CERAD (Consortium to Establish a Registry for Alzheimer’s Disease) Neuropsychology Assessment Battery: 35 Years and Counting, Journal of Alzheimer's Disease, 93, 1, (1-27), (2023).https://doi.org/10.3233/JAD-230026
Loading...
View Options
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
Purchase this article to access the full text.
